X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4689) 4689
Publication (371) 371
Newsletter (68) 68
Book Review (35) 35
Book Chapter (32) 32
Magazine Article (16) 16
Dissertation (15) 15
Newspaper Article (12) 12
Journal / eJournal (9) 9
Web Resource (5) 5
Conference Proceeding (4) 4
Book / eBook (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
praziquantel (2727) 2727
animals (2656) 2656
humans (2603) 2603
praziquantel - therapeutic use (2073) 2073
male (1913) 1913
female (1798) 1798
index medicus (1712) 1712
parasitology (1341) 1341
schistosomiasis (1148) 1148
adult (1109) 1109
anthelmintics - therapeutic use (1011) 1011
child (957) 957
adolescent (916) 916
tropical medicine (915) 915
parasitic diseases (868) 868
mice (682) 682
middle aged (668) 668
praziquantel - administration & dosage (649) 649
schistosomiasis mansoni - drug therapy (643) 643
chemotherapy (593) 593
infections (557) 557
infectious diseases (556) 556
schistosoma mansoni (549) 549
treatment outcome (516) 516
prevalence (508) 508
praziquantel - pharmacology (503) 503
infection (492) 492
feces - parasitology (472) 472
mansoni (470) 470
parasite egg count (457) 457
schistosomiasis - drug therapy (448) 448
health aspects (440) 440
child, preschool (438) 438
anthelmintics - administration & dosage (431) 431
schistosoma mansoni - drug effects (407) 407
research (406) 406
public, environmental & occupational health (405) 405
immunology (391) 391
tropical diseases (371) 371
efficacy (367) 367
diagnosis (352) 352
microbiology (351) 351
parasites (347) 347
albendazole (339) 339
research article (324) 324
morbidity (318) 318
analysis (310) 310
schistosomiasis haematobia - drug therapy (307) 307
resistance (304) 304
anthelmintics - pharmacology (298) 298
aged (294) 294
pharmacology & pharmacy (290) 290
epidemiology (288) 288
arctic medicine. tropical medicine (271) 271
children (271) 271
praziquantel - adverse effects (248) 248
schistosomicides - therapeutic use (243) 243
public health (242) 242
albendazole - therapeutic use (241) 241
public aspects of medicine (237) 237
drug therapy, combination (230) 230
schistosoma haematobium (229) 229
care and treatment (228) 228
schistosomiasis mansoni - parasitology (219) 219
neglected tropical diseases (214) 214
veterinary sciences (213) 213
young adult (213) 213
medicine (211) 211
eggs (206) 206
time factors (206) 206
neurocysticercosis (204) 204
drugs (201) 201
drug therapy (199) 199
cysticercosis - drug therapy (197) 197
in-vitro (193) 193
schistosomiasis mansoni - epidemiology (193) 193
schistosoma (190) 190
drug resistance (188) 188
risk factors (187) 187
liver (185) 185
schistosomiasis japonica - drug therapy (185) 185
cysticercosis (178) 178
schistosoma-mansoni (174) 174
antigens (172) 172
schistosomiasis - epidemiology (172) 172
follow-up studies (170) 170
disease (169) 169
dogs (169) 169
medicine, general & internal (168) 168
schistosomiasis haematobia - epidemiology (166) 166
liver - parasitology (164) 164
infant (163) 163
medical research (161) 161
enzyme-linked immunosorbent assay (159) 159
dosage and administration (158) 158
dose-response relationship, drug (158) 158
schistosoma mansoni - isolation & purification (157) 157
studies (153) 153
biomedicine (151) 151
disease models, animal (151) 151
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4330) 4330
French (125) 125
Chinese (90) 90
Spanish (66) 66
German (48) 48
Portuguese (48) 48
Russian (45) 45
Japanese (18) 18
Korean (14) 14
Dutch (6) 6
Italian (5) 5
Polish (4) 4
Turkish (4) 4
Danish (3) 3
Norwegian (3) 3
Indonesian (2) 2
Romanian (2) 2
Serbian (2) 2
Croatian (1) 1
Czech (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Treatment of Schistosomiasis: Gathering Stones Together, 12/1995
In this paper the treatment of schistosomiasis is examined under the following headings: cercarial dermatitis, Katayama fever, schistosomiasis in the... 
schistosomiasis - praziquantel - oxamniquine - corticosteroids
Journal
Parasite, ISSN 1252-607X, 2014, Volume 21, p. 70
The search for novel therapeutic options to cure alveolar echinococcosis (AE), due to the metacestode of Echinococcus multilocularis, is ongoing, and these... 
Drugs | Host-parasite interaction | Alveolar echinococcosis (AE) | Echinococcus multilocularis chemotherapy | In vitro culture | METACESTODE VESICLES | METASTASES FORMATION | PRAZIQUANTEL TREATMENT | AMPHOTERICIN-B | IN-VITRO EFFICACY | MURINE ALVEOLAR ECHINOCOCCOSIS | MULTILOCULARIS PRIMARY-CELLS | MOLECULAR-CLONING | GLUTATHIONE-S-TRANSFERASE | CYSTIC ECHINOCOCCOSIS | PARASITOLOGY | Echinococcus multilocularis - growth & development | Thiophenes - therapeutic use | Humans | Thiazoles - therapeutic use | Molecular Targeted Therapy | Cytostatic Agents - therapeutic use | Echinococcosis, Hepatic - drug therapy | Mefloquine - therapeutic use | Echinococcosis, Hepatic - parasitology | Larva - drug effects | Drug Design | Imidazoles - therapeutic use | Cytostatic Agents - pharmacology | Drug Evaluation, Preclinical | Anthelmintics - therapeutic use | Albendazole - therapeutic use | Echinococcus multilocularis - physiology | Clarithromycin - therapeutic use | Imidazoles - pharmacology | Echinococcus multilocularis - drug effects | Forecasting | Cell Division - drug effects | Anthelmintics - classification | Host-Parasite Interactions - drug effects | Animals | Echinococcosis - drug therapy | Anthelmintics - pharmacology | Echinococcus multilocularis - ultrastructure | Mebendazole - therapeutic use | Mice | Thiazoles - pharmacology | Clarithromycin - pharmacology | Guanidines - therapeutic use | Helminth Proteins - antagonists & inhibitors | Enzymes | Effectiveness | Target recognition | Cultures | Identification | Genomes | Parasites | Gene expression | Drug screening | Molecular chains | Exploitation | Mebendazole | Laboratory tests | Albendazole | Host-parasite interactions | Drug discovery | Laboratory animals | Alveoli | Cancer | Echinococcosis | Dominique A. Vuitton, Laurence Millon, Bruno Gottstein and Patrick Giraudoux | Innovation for the Management of Echinococcosis. Invited editors | Review
Journal Article
Journal Article
Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa, 12/2005
Several cases of therapeutic failure of praziquantel used for the treatment of urinary schistosomiasis have been reported. Alternative drugs, like niridazol... 
schistosomiasis therapeutic failure - praziquantel - Schistosoma haematobium - Africa - Brazil
Journal
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 8, pp. 657 - 657
  According to a joint report by the UN's Food and Agriculture Organization and WHO, Research priorities for helminth infections, neurocysticercosis is the... 
Infectious Disease | INFECTIOUS DISEASES | Albendazole - therapeutic use | Humans | Neurocysticercosis - drug therapy | Female | Male | Praziquantel - therapeutic use | Anthelmintics - therapeutic use | Infections | Disease | Cysts | Drug therapy | Drug dosages | Epilepsy
Journal Article
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 06/2017, Volume 56, Issue 6, pp. 583 - 606
Introduction Neglected tropical diseases (NTDs) affect more than one billion people, mainly living in developing countries. For most of these NTDs, treatment... 
GLOBAL BURDEN | ALBENDAZOLE SULFOXIDE | PLASMA | POPULATION PHARMACOKINETICS | MUCOSAL LEISHMANIASIS | IVERMECTIN | PHARMACOLOGY & PHARMACY | SODIUM STIBOGLUCONATE | CEREBROSPINAL-FLUID | VISCERAL LEISHMANIASIS | ANTIMONY | Neglected Diseases - drug therapy | Neglected Diseases - metabolism | Pharmacokinetics | Humans | Tropical Medicine
Journal Article